IP Library › Granted Patent US 12,217,851
Granted Patent B2
US 12,217,851 · App. 17/595,191 · Granted Feb 4, 2025

Identification of candidate signs indicative of an NTRK oncogenic fusion

Inventors: Arndt Schmitz (Berlin, DE); Eren Metin Elci (Bensheim, DE); Faidra Stavropoulou (Berlin, DE); Mikhail Kachala (Cologne, DE); Antti Karlsson (Parainen, FI); Mikko Tukiainen (Kaarina, FI)
G16H30/40G06N3/04G06T7/0012G06V20/698G16H10/40G16H10/60G16H50/20G06T2207/30004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,217,851
App. No.
17/595,191
Granted
Feb 4, 2025
Kind
B2
Abstract

The present invention relates to the identification of one or more candidate signs indicative of an NTRK oncogenic fusion within patient data. Subject matter of the present invention are a computer-implemented method, a system, and a non-transitory computer-readable storage medium for determining a probability value from patient data associated with a subject patient, the probability value indicating the probability of the subject patient suffering from cancer caused by a mutation of a neurotrophic receptor tyrosine kinase (NTRK) gene.

Claims (26)

1. A computer-implemented method for identifying one or more candidate signs indicative of an NTRK oncogenic fusion within patient data associated with a subject patient, the method comprising:

receiving historical patient data for which one or more candidate signs indicative of an NTRK oncogenic fusion have been verified or excluded, the historical patient data comprising a plurality of histopathological images of tumor tissue;

training a prediction model via machine learning to predict a probability of cancer caused by the NTRK oncogenic fusion for each histological image of the plurality of histopathological images, thereby obtaining a trained prediction model;

receiving patient data of a subject patient suffering from cancer, the patient data comprising at least one histopathological image of tumor tissue of the subject patient;

inputting the patient data into the trained prediction model, the trained prediction model being configured for identifying within the patient data one or more characteristics of an NTRK oncogenic fusion;

receiving as an output from the trained prediction model a probability value, the probability value indicating the probability of the subject patient suffering from cancer caused by an NTRK oncogenic fusion;

comparing the probability value with a predefined threshold value; and

in the event that the probability value is equal to or greater than the threshold value: initiating further investigations for verification of the indication that the subject patient suffers from cancer caused by an NTRK oncogenic fusion.

2. A system, comprising:

a processor; and

a memory storing an application program configured to perform, when executed by the processor, an operation for identifying one or more candidate signs indicative of an NTRK oncogenic fusion within patient data associated with a subject patient, the operation comprising:

receiving historical patient data for which the one or more candidate signs indicative of the NTRK oncogenic fusion have been verified or excluded, the historical patient data comprising a plurality of histopathological images of tumor tissue;

training a prediction model via machine learning to predict a probability of cancer caused by the NTRK oncogenic fusion for each histological image of the plurality of histopathological images, thereby obtaining a trained prediction model;

receiving patient data of a subject patient suffering from cancer, the patient data comprising at least one histopathological image of tumor tissue of the subject patient;

inputting the patient data into the trained prediction model, the trained prediction model being configured for identifying within the patient data one or more characteristics of an NTRK oncogenic fusion;

receiving as an output from the trained prediction model a probability value, the probability value indicating the probability of the subject patient suffering from cancer caused by an NTRK oncogenic fusion;

comparing the probability value with a predefined threshold value; and

in the event that the probability value is equal to or greater than the threshold value: initiating further investigations for verification of the indication that the subject patient suffers from cancer caused by an NTRK oncogenic fusion.

3. A non-transitory computer-readable storage medium comprising processor-executable instructions with which to perform an operation for identifying one or more candidate signs indicative of an NTRK oncogenic fusion within patient data associated with a subject patient, the operation comprising:

receiving historical patient data for which one or more candidate signs indicative of an NTRK oncogenic fusion have been verified or excluded, the historical patient data comprising a plurality of histopathological images of tumor tissue;

training a prediction model via machine learning to predict a probability of cancer caused by the NTRK oncogenic fusion for each histological image of the plurality of histopathological images, thereby obtaining a trained prediction model;

receiving patient data of a subject patient suffering from cancer, the patient data comprising at least one histopathological image of tumor tissue of the subject patient;

inputting the patient data into the trained prediction model, the trained prediction model being configured for identifying within the patient data one or more characteristics of an NTRK oncogenic fusion;

receiving as an output from the trained prediction model a probability value, the probability value indicating the probability of the subject patient suffering from cancer caused by an NTRK oncogenic fusion;

comparing the probability value with a predefined threshold value; and

in the event that the probability value is equal to or greater than the threshold value: initiating further investigations for verification of the indication that the subject patient suffers from cancer caused by an NTRK oncogenic fusion.

Priority Claims (1)
EP 19173832 · May 10, 2019 · regional
Continuity (1)
Related Publication 20220223261A1 · Jul 14, 2022
References Cited (16)
US 9922421B1 · Degani · 2018 [cited by examiner]
US 12002544B2 · Lo · 2024 [cited by examiner]
US 20050262031A1 · Saidi et al. · 2005 [cited by applicant]
US 20090252391A1 · Matsuda · 2009 [cited by examiner]
US 20170316567A1 · Kotoku · 2017 [cited by examiner]
US 20180130204A1 · Degani · 2018 [cited by examiner]
US 20200327659A1 · Sati · 2020 [cited by examiner]
US 20200342600A1 · Sjöstrand · 2020 [cited by examiner]
WO 2019084697A1 · 2019 [cited by applicant]
Safoora Deihimi et al, BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations, 2017, Oncotarget vol. 8 (Year: 2017). [cited by examiner]
Arunachalam, H. B. et al., Apr. 17, 2019, “Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models,” PLOS ONE, 14(4):e0210706. [cited by applicant]
Coudray, N. et al., Oct. 2018, “Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning,” Nature Medicine, 24:1559-1567. [cited by applicant]
David, J. L. et al., 2018, “Infantile NTRK-associated Mesenchymal Tumors,” Pediatric and Developmental Pathology, 21(1):68-78. no date available. [cited by applicant]
Extended European Search Report dated Nov. 18, 2019 for European Application No. 19173832.7, 11 pages. [cited by applicant]
Penault-Llorca, F. et al., May 9, 2019, “Testing algorithm for identification of patients with TRK fusion cancer,” J Clin. Pathol., 72:460-467. [cited by applicant]
Davis, J. L. et al. (2017). “Infantile NTRK-associated Mesenchymal Tumors” Pediatric and Developmental Pathology, vol. 21(1), Jul. 6, 2017, pp. 68-78. [cited by applicant]